Edakkadath Raghavan Sindhu

Suggest Changes
Learn More
We set out to determine the effect of oxycarotenoid lutein on reducing cardiac and renal toxicity induced by doxorubicin (DXR). We started with oral administration in rats of lutein for 15 d before(More)
Oxycarotenoid lutein (3,3'-dihydroxy-β,ε-carotene) was checked for anticarcinogenic activity against N-nitrosodiethylamine-induced hepatocellular carcinoma (HCC) in rats. Lutein could significantly(More)